Get access

Coverage and Preventive Screening

Authors

  • Daniella Meeker,

    1. RAND Corporation, 1776 Main Street, Santa Monica, CA 90407-2138
    Search for more papers by this author
    • Address correspondence to Daniella Meeker, Ph.D., Information Scientist, RAND Corporation, 1776 Main Street, Santa Monica, CA 90407-2138; e-mail: dmeeker@rand.org. Geoffrey F. Joyce, Ph.D., Associate Professor, is with the University of Southern California School of Pharmacy, Los Angeles, CA. Geoffrey F. Joyce, Ph.D., Associate Professor, Economist, Jesse Malkin, M.Phil., Ph.D., Adjunct Economist, Dana P. Goldman, Ph.D., Professor, Economist, are with the RAND Corporation, Santa Monica, CA. Steven M. Teutsch, M.D., M.P.H., Chief Science Officer, is with the Los Angeles County Department of Public Health, Los Angeles, CA. Anne C. Haddix, Ph.D., Senior Policy Advisor, is with the Office of the Associate Director for Policy, Centers for Disease Control and Prevention, Atlanta, GA. Dana P. Goldman, Ph.D., Professor, is with the University of Southern California, Los Angeles, CA. Dana P. Goldman, Ph.D., Professor, Director, is also with the Leonard D. Schaeffer Center for Health Policy and Economics, Los Angeles, CA.

  • Geoffrey F. Joyce,

    1. University of Southern California School of Pharmacy, Los Angeles, CA
    2. RAND Corporation, Santa Monica, CA
    Search for more papers by this author
  • Jesse Malkin,

    1. RAND Corporation, Santa Monica, CA
    Search for more papers by this author
  • Steven M. Teutsch,

    1. Los Angeles County Department of Public Health, Los Angeles, CA
    Search for more papers by this author
  • Anne C. Haddix,

    1. Centers for Disease Control and Prevention, Atlanta, GA
    Search for more papers by this author
  • Dana P. Goldman

    1. RAND Corporation, Santa Monica, CA
    2. University of Southern California, Los Angeles, CA
    3. Leonard D. Schaeffer Center for Health Policy and Economics, Los Angeles, CA.
    Search for more papers by this author

Abstract

Context. Preventive care has been shown as a high-value health care service. Many employers now offer expanded coverage of preventive care to encourage utilization.

Objective. To determine whether expanding coverage is an effective means to encourage utilization.

Design. Comparison of screening rates before and after introduction of deductible-free coverage.

Setting. People insured through large corporations between 2002 and 2006.

Patients or Other Participants. Preferred Provider Organization (PPO) enrollees from an employer introducing deductible-free coverage, and a control group enrolled in a PPO from a second employer with no policy change.

Main Outcome Measures. Adjusted probability of endoscopy, fecal occult blood test (FOBT), lipid screens, mammography, and Papanicolaou (pap) smears.

Intervention. Introduction of first-dollar coverage (FDC) of preventive services in 2003.

Results. After adjusting for demographics and secular trends, there were between 23 and 78 additional uses per 1,000 eligible patients of covered preventive screens (lipid screens, pap smears, mammograms, and FOBT), with no significant changes in the control group or in a service without FDC (endoscopy).

Conclusions. FDC improves utilization modestly among healthy individuals, particularly those in lower deductible plans. Compliance with guidelines can be encouraged by lowering out-of-pocket costs, but patients' predisposing characteristics merit attention.

Ancillary